UBS Maintains Buy Rating on CHOW TAI FOOK, Management Affirms FY2026 Guidance

Stock News
04/23

UBS has issued a research report stating that CHOW TAI FOOK's (01929) sales performance for the fourth fiscal quarter of 2026, covering the three months ended March, was broadly in line with the market's downwardly revised expectations. This was attributed to pressured demand in Mainland China, which was offset by stronger-than-expected demand in other markets. During the period, the group's overall sales declined by 1.5% year-on-year. Sales in the Mainland China market decreased by 8.2%, while sales in markets outside Mainland China grew by 58.5%. Regarding same-store sales growth, Mainland China self-operated retail stores recorded a positive 0.2% growth, Mainland China franchise stores recorded a negative 5.8% growth, and other markets achieved a positive 40.1% growth. Sales through the Hainan duty-free channel increased by 141% year-on-year, while international market sales grew by 20%. UBS has assigned the group a "Buy" rating with a target price of HK$18.5. Management has maintained its guidance for the 2026 fiscal year, expecting revenue to achieve low to mid-single-digit growth and same-store sales growth to reach mid to high-single digits. The gross profit margin is forecasted to be between 31.5% and 32.5%, with hedging losses expected to be similar to the HK$6.2 billion recorded in the 2025 fiscal year. Guidance for the 2027 fiscal year will be provided upon the announcement of the full-year results in June.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10